+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 65Years - 90Years
All Genders
ID05635877

Low-dose Esmolol to Prevent Heart Injury After Non-Heart Surgery in Frail Older Adults A Multicenter, Randomized, Double-blind Study

Led by Yongtao Sun · Updated on 2023-03-29

2000

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research investigates the relationship between preoperative frailty and myocardial injury after non-cardiac surgery in elderly patients. It aims to identify factors that predict myocardial injury in frail elderly patients and to explore the effects of low-dose esmolol on reducing this injury. The study focuses on elderly patients aged 65 to 90 undergoing non-cardiac surgery, addressing a critical concern about cardiac complications in this vulnerable group. Participants are randomly assigned to receive either low-dose esmolol or a placebo during surgery. The esmolol group receives a 0.5 mgkg loading dose followed by a continuous infusion of 10 mcgkgmin, while the control group receives an equal volume of normal saline. Both groups use patient-controlled analgesia pumps with sufentanil for postoperative pain management. The treatment continues until the end of surgery, with postoperative pain monitored and managed as needed. During the study, researchers monitor the incidence of myocardial injury within three days after surgery and record outcomes up to 30 days post-operation. Participants undergo assessments including monitoring heart rate, blood pressure, and pain levels. The trial also tracks any adverse effects and overall recovery progress. The study is designed as a double-blind, randomized controlled trial to evaluate the safety and effects of esmolol in frail elderly patients undergoing non-cardiac surgery.

CONDITIONS

Brief Title

Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients

Research Team

Y

yongtao Sun, PH.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here